Cemindo Gemilang Tbk PT
IDX:CMNT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
865
1 175
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Cemindo Gemilang Tbk PT
Cemindo Gemilang Tbk PT
Non-Reccuring Items
Cemindo Gemilang Tbk PT
Non-Reccuring Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cemindo Gemilang Tbk PT
IDX:CMNT
|
Non-Reccuring Items
Rp1.9B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Semen Indonesia (Persero) Tbk PT
IDX:SMGR
|
Non-Reccuring Items
Rp1.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-14%
|
|
|
Solusi Bangun Indonesia Tbk PT
IDX:SMCB
|
Non-Reccuring Items
-Rp525m
|
CAGR 3-Years
69%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
|
Indocement Tunggal Prakarsa Tbk PT
IDX:INTP
|
Non-Reccuring Items
-Rp1.8B
|
CAGR 3-Years
60%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Semen Baturaja (Persero) Tbk PT
IDX:SMBR
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Waskita Beton Precast Tbk PT
IDX:WSBP
|
Non-Reccuring Items
Rp1T
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cemindo Gemilang Tbk PT
Glance View
In the heart of Indonesia's bustling construction landscape, Cemindo Gemilang Tbk PT stands out as a formidable player within the cement industry. Founded with a vision to meet the burgeoning infrastructure demands of Indonesia and its neighbors, Cemindo Gemilang has carved out a significant niche in the production and distribution of top-tier cement products. The company operates under the dynamic brand "Semen Merah Putih," which has become synonymous with quality and reliability. Anchored by its state-of-the-art integrated cement plant in Banten and supported by grinding facilities in other strategic locations, Cemindo Gemilang leverages its robust production capacity to supply cement for a myriad of construction needs, ranging from large-scale infrastructure projects to residential developments. The seamless integration of its manufacturing and distribution capabilities ensures an efficient supply chain, enabling it to cater to both domestic and export markets effectively. Cemindo Gemilang's business model is driven by its diverse product offerings that extend beyond traditional cement. It capitalizes on selling various types of cement to suit different construction needs, including Ordinary Portland Cement and Pozzolan Portland Cement. Additionally, the company's strategic involvement in clinker trade broadens its revenue streams. As the construction industry thrives on robust demand, particularly with the government's focus on enhancing infrastructure, Cemindo Gemilang's position is reinforced by its ability to adapt to market dynamics and its commitment to sustainability. The company's focus on innovation and quality, coupled with strategic partnerships and a keen understanding of local market nuances, ensures that Cemindo Gemilang remains a pivotal contributor to Indonesia's development fabric while exploring global opportunities.
See Also
What is Cemindo Gemilang Tbk PT's Non-Reccuring Items?
Non-Reccuring Items
1.9B
IDR
Based on the financial report for Dec 31, 2023, Cemindo Gemilang Tbk PT's Non-Reccuring Items amounts to 1.9B IDR.
What is Cemindo Gemilang Tbk PT's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 5Y
-23%
Over the last year, the Non-Reccuring Items growth was -51%. The average annual Non-Reccuring Items growth rates for Cemindo Gemilang Tbk PT have been -34% over the past three years , -23% over the past five years .
You don't have any saved screeners yet
